DK0542934T3 - Anvendelse af somatostatinanaloger til behandling af melanomer - Google Patents

Anvendelse af somatostatinanaloger til behandling af melanomer

Info

Publication number
DK0542934T3
DK0542934T3 DK92906420T DK92906420T DK0542934T3 DK 0542934 T3 DK0542934 T3 DK 0542934T3 DK 92906420 T DK92906420 T DK 92906420T DK 92906420 T DK92906420 T DK 92906420T DK 0542934 T3 DK0542934 T3 DK 0542934T3
Authority
DK
Denmark
Prior art keywords
melanomas
treatment
somatostatin analogues
melanoma
skin
Prior art date
Application number
DK92906420T
Other languages
Danish (da)
English (en)
Inventor
Jacques-Pierre Moreau
Arthur E Bogden
Original Assignee
Biomeasure Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomeasure Inc filed Critical Biomeasure Inc
Application granted granted Critical
Publication of DK0542934T3 publication Critical patent/DK0542934T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK92906420T 1991-02-08 1992-02-07 Anvendelse af somatostatinanaloger til behandling af melanomer DK0542934T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65286391A 1991-02-08 1991-02-08
PCT/US1992/001027 WO1992013554A1 (en) 1991-02-08 1992-02-07 Method of treating benign and malignant proliferative skin disease

Publications (1)

Publication Number Publication Date
DK0542934T3 true DK0542934T3 (da) 1999-11-22

Family

ID=24618499

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92906420T DK0542934T3 (da) 1991-02-08 1992-02-07 Anvendelse af somatostatinanaloger til behandling af melanomer

Country Status (12)

Country Link
US (1) US6087337A (es)
EP (1) EP0542934B1 (es)
JP (1) JPH05506254A (es)
AT (1) ATE181240T1 (es)
CA (1) CA2079896A1 (es)
DE (1) DE69229436T2 (es)
DK (1) DK0542934T3 (es)
ES (1) ES2134798T3 (es)
GR (1) GR3030856T3 (es)
IE (1) IE920416A1 (es)
PT (1) PT100111B (es)
WO (1) WO1992013554A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783170A (en) * 1991-11-27 1998-07-21 Diatide, Inc. Peptide-metal chelate conjugates
US5620675A (en) 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US5871711A (en) * 1992-06-23 1999-02-16 Diatide, Inc. Radioactively-labeled somatostatin-derived peptides for imaging and therapeutic uses
US5716596A (en) * 1992-06-23 1998-02-10 Diatide, Inc. Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
US5932189A (en) * 1994-07-29 1999-08-03 Diatech, Inc. Cyclic peptide somatostatin analogs
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
JP6869720B2 (ja) * 2013-06-13 2021-05-12 アンチセンス セラピューティクス リミテッド 併用療法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904594A (en) * 1973-07-02 1975-09-09 Salk Inst For Biological Studi Somatostatin and acylated des-(ala' 1', gly' 2') derivatives thereof
US4310518A (en) * 1979-10-31 1982-01-12 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
US4235886A (en) * 1979-10-31 1980-11-25 Merck & Co., Inc. Cyclic hexapeptide somatostatin analogs
DE19375086I2 (de) * 1979-11-27 2003-01-09 Novartis Ag Polypeptide Verfahren zu ihrer Herstellung pharmazeutische Zusammensetzungen die diese Polypeptide enthalten und ihre Verwendung
US4360516A (en) * 1981-04-13 1982-11-23 Merck & Co., Inc. Modified D-retro cyclic hexapeptide somatostatin analogs
US4485101A (en) * 1983-10-11 1984-11-27 Administrators Of The Tulane Educational Fund Peptides
GB8423431D0 (en) * 1984-09-17 1984-10-24 Sandoz Ltd Organic compounds
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides
US4585755A (en) * 1985-04-29 1986-04-29 Merck & Co., Inc. Cyclic and bridged cyclic somatostatin analogs useful as local anti-inflammatory agents
US4904642A (en) * 1985-09-12 1990-02-27 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US4853371A (en) * 1986-06-17 1989-08-01 The Administrators Of The Tulane Educational Fund Therapeutic somatostatin analogs
US4871717A (en) * 1987-01-07 1989-10-03 Administrators Of The Tulane Educational Fund Peptides
DK375789A (da) * 1988-08-18 1990-02-19 Syntex Inc Peptidderivater
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
JP2882679B2 (ja) * 1989-04-26 1999-04-12 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 線状ソマトスタチン類似体
CA2046594A1 (en) * 1989-12-08 1991-06-09 David H. Coy Octapeptide analogs of somatostatin having threonine at the sixth position
GB9004017D0 (en) * 1990-02-22 1990-04-18 Krenning Eric P Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
ES2134798T3 (es) 1999-10-16
CA2079896A1 (en) 1992-08-09
WO1992013554A1 (en) 1992-08-20
GR3030856T3 (en) 1999-11-30
DE69229436T2 (de) 1999-11-25
US6087337A (en) 2000-07-11
EP0542934B1 (en) 1999-06-16
EP0542934A1 (en) 1993-05-26
EP0542934A4 (en) 1993-07-07
IE920416A1 (en) 1992-08-12
ATE181240T1 (de) 1999-07-15
DE69229436D1 (de) 1999-07-22
PT100111A (pt) 1993-06-30
PT100111B (pt) 1999-06-30
JPH05506254A (ja) 1993-09-16

Similar Documents

Publication Publication Date Title
EE9900481A (et) Väikesed molekulid, mida kasutatakse põletikuliste haiguste raviks
DK0954299T3 (da) Thyroxin-analoger uden signifikant hormonal aktivitet til behandling af ondartede tumorer
EA200000723A1 (ru) Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола
BR9805544C1 (pt) Uso de um composto.
DE69738615D1 (de) Verwendung von glp-1 oder analogen zur behandlung von myokardischem infarkt
DE3889536D1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
DE3689363D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung der Metastasen von Krebstumoren.
DK0981341T3 (da) Anvendelse af betulinsyrederivater til behandling og forebyggelse af melanom
DK0900200T3 (da) Farmaceutiske sammensætninger til forebyggelse og behandling af sygdom i centralnervesystemet
ATE201597T1 (de) Verabreichung von riluzol zur behandlung von neuro-aids
DE68907423D1 (de) Behandlung der akne.
DK57882A (da) Fremgangsmaade til fremstilling af tetrahydronaphthalen-og indanderivater
DK0542934T3 (da) Anvendelse af somatostatinanaloger til behandling af melanomer
DK71387A (da) Terapeutisk middel til behandling af psoriasis
DE68903092D1 (de) Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
ES502654A0 (es) Un procedimiento para la preparacion de nuevos derivados de 2-propanol
DK0994884T3 (da) Diphosphonsyresalte til behandling af osteoporose
ATE419346T1 (de) Hemmung der bildung von atherosklerotischen wunden mittels afabp antisens nukleinsäuren
SE9601396D0 (sv) New therapeutic treatment 2
DK0986393T3 (da) Anvendelse af et nitroxid eller et prodrug heraf ved profylaktisk og terapeutisk behandling af cancer
DK0799618T3 (da) Anvendelse af alpha1-adrenoreceptor-antagonister i fremstillingen af et medikament til forebyggelsen og behandlingen af cancer
DE69218200D1 (de) Behandlung von leberkrebs
DE69924979D1 (de) Behandlung von chronischen schmerzen
ATE240100T1 (de) Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten
HUP9904578A2 (hu) Xanomelin alkalmazása bipoláris depresszió kezelésére szolgáló gyógyszerkészítmények előállítására